Cargando…
Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
Autores principales: | Lyski, Zoe L., Kim, Myung S., Xthona Lee, David, Raué, Hans-Peter, Raghunathan, Vikram, Griffin, Janet, Ryan, Debbie, Brunton, Amanda E., Curlin, Marcel E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651482/ https://www.ncbi.nlm.nih.gov/pubmed/34872103 http://dx.doi.org/10.1182/bloodadvances.2021006633 |
Ejemplares similares
-
Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia
por: Lyski, Zoe L., et al.
Publicado: (2022) -
Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients
por: Lyski, Zoe L., et al.
Publicado: (2021) -
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022) -
SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern.
por: Lyski, Zoe L., et al.
Publicado: (2021) -
Establishment of Monoclonal Antibody Standards for Quantitative Serological Diagnosis of SARS-CoV-2 in Low-Incidence Settings
por: Thomas, Archana, et al.
Publicado: (2021)